ANGELALIGN6699.HKValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 16, 2026, ANGELALIGN (6699.HK) trades at a P/E of 42.90x, P/B of 4.25x, P/S of 4.01x, and a dividend yield of 12.60%.
Longitudinal percentile comparison: P/E sits at the 2nd percentile over the trailing 10Y window (vs. 1st percentile over 3Y); P/B sits at the 67th percentile over the trailing 10Y window (vs. 96th percentile over 3Y); P/S sits at the 4th percentile over the trailing 10Y window (vs. 7th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 81st percentile within its industry and the 88th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 12.60%, ranking at the 100th percentile over the trailing 20Y window.
Notably, P/E and P/B aren't telling quite the same story, 64.2 points apart — worth checking the full percentile matrix on this page for the complete picture. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. ANGELALIGN operates in the Other Pharmaceuticals and Medical Services sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: HKG: 6699 · SEHK: 6699 · 6699
Want the full picture on whether ANGELALIGN (6699.HK) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 42.90 | ||||||
| P/B (MRQ) | 4.25 | ||||||
| P/S (TTM) | 4.01 | ||||||
| Dividend Yield | 12.60% | ||||||
| Buyback + Div Yield | 12.60% |